Skip to main content
In stock | Targeted Therapy (Investigational)

Zoldonrasib

Oncology Type Solid Tumour
Drug Class / Mechanism RAS(ON) G12D-Selective Tri-Complex Inhibitor
No Image
Description

Zoldonrasib is classified as a RAS(ON) G12D-Selective Tri-Complex Inhibitor, sourced for use within our Targeted Therapy (Investigational) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Targeted Therapy (Investigational)
Oncology Type Solid Tumour

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3